News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
865,389 Results
Type
Article (87654)
Company Profile (824)
Press Release (776895)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233150)
Career Advice (4142)
Deals (39826)
Drug Delivery (141)
Drug Development (91320)
Employer Resources (203)
FDA (18325)
Job Trends (17412)
News (397609)
Policy (39939)
Tag
Academia (3006)
Academic (2)
Accelerated approval (22)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (157)
Alzheimer's disease (1729)
Antibody-drug conjugate (ADC) (285)
Approvals (18399)
Artificial intelligence (556)
Autoimmune disease (122)
Automation (32)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (178)
Biotechnology (487)
Bladder cancer (143)
Brain cancer (57)
Breast cancer (551)
Cancer (4413)
Cardiovascular disease (394)
Career advice (3564)
Career pathing (39)
CAR-T (266)
CDC (57)
Cell therapy (735)
Cervical cancer (34)
Clinical research (76175)
Collaboration (1524)
Company closure (4)
Compensation (1010)
Complete response letters (64)
COVID-19 (2968)
CRISPR (92)
C-suite (682)
Cystic fibrosis (145)
Data (5373)
Decentralized trials (2)
Denatured (66)
Depression (125)
Diabetes (483)
Diagnostics (7137)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (260)
Drug pricing (202)
Drug shortages (36)
Duchenne muscular dystrophy (215)
Earnings (99840)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (134126)
Executive appointments (1005)
FDA (21050)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1380)
Gene editing (197)
Generative AI (55)
Gene therapy (599)
GLP-1 (1067)
Government (5408)
Grass and pollen (8)
Guidances (378)
Healthcare (20941)
HIV (54)
Huntington's disease (43)
IgA nephropathy (79)
Immunology and inflammation (268)
Immuno-oncology (27)
Indications (68)
Infectious disease (3232)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (108)
Intellectual property (207)
Interviews (816)
IPO (17937)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (627)
Lymphoma (310)
Machine learning (35)
Management (66)
Manufacturing (709)
MASH (164)
Medical device (14946)
Medtech (14984)
Mergers & acquisitions (22841)
Metabolic disorders (1255)
Multiple sclerosis (147)
NASH (23)
Neurodegenerative disease (283)
Neuropsychiatric disorders (78)
Neuroscience (2875)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (597)
Opinion (322)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (190)
Parkinson's disease (260)
Partnered (32)
Patents (447)
Patient recruitment (366)
Peanut (58)
People (66502)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23496)
Phase II (33058)
Phase III (24926)
Pipeline (3508)
Policy (314)
Postmarket research (3554)
Preclinical (10623)
Press Release (72)
Prostate cancer (220)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (738)
Real estate (7431)
Recruiting (80)
Regulatory (28344)
Reports (65)
Research institute (2709)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (81)
Schizophrenia (144)
Series A (223)
Series B (168)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1080)
Venture capital (74)
Weight loss (420)
Women's health (70)
Worklife (21)
Date
Today (128)
Last 7 days (625)
Last 30 days (3786)
Last 365 days (33398)
2025 (30925)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (318)
Arkansas (14)
Asia (51179)
Australia (9001)
California (10487)
Canada (3076)
China (992)
Colorado (441)
Connecticut (473)
Delaware (302)
Europe (117735)
Florida (1533)
Georgia (340)
Hawaii (3)
Idaho (68)
Illinois (860)
India (59)
Indiana (506)
Iowa (21)
Japan (354)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1375)
Massachusetts (7790)
Michigan (332)
Minnesota (609)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (27)
Nevada (114)
New Hampshire (81)
New Jersey (2874)
New Mexico (32)
New York (2808)
North Carolina (1503)
North Dakota (10)
Northern California (4896)
Ohio (319)
Oklahoma (22)
Oregon (51)
Pennsylvania (2147)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (58)
South Dakota (1)
Southern California (4026)
Tennessee (162)
Texas (1637)
United States (38242)
Utah (316)
Vermont (1)
Virginia (266)
Washington D.C. (85)
Washington State (878)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
There are 865,389 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
·
3 min read
Press Releases
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
November 26, 2025
·
4 min read
Press Releases
Optimi Health to Supply MDMA to MAPS Israel’s Clinical Trial for Trauma-Related PTSD
Approved multicenter study sponsored by Sheba Medical Center to compare group and individual MDMA-assisted therapy for 168 patients experiencing trauma-related PTSD
November 26, 2025
·
6 min read
Press Releases
Oncology Molecular Diagnostic Market Size Worth USD 8.50 Bn by 2034
November 26, 2025
·
1 min read
Press Releases
Elanco executive appointed as Board Observer
November 26, 2025
·
1 min read
Approvals
Otsuka Secures IgAN Win as FDA Approves First Anti-APRIL Antibody
Analysts at Guggenheim Partners expect Voyxact to see “broad commercial uptake” given its relatively broad label compared with previous accelerated approvals for IgA nephropathy.
November 26, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Novo’s GLP-1s Highlight List as CMS Unveils Final Prices For Second Cycle of Drug Negotiations
The discounts should be compared against the drugs’ “ultimate net price” rather than their indicated list price to gauge the true impact of the negotiations, BMO Capital Markets analysts said.
November 26, 2025
·
2 min read
·
Tristan Manalac
Approvals
AstraZeneca Notches Another Indication for Imfinzi, Pushing PD-L1 Blocker Into Stomach Cancer
Imfinzi is the first immunotherapy approved for perioperative use to treat gastric and gastroesophageal junction cancers.
November 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
November 26, 2025
·
7 min read
Press Releases
Lighthouse Pharmaceuticals To Present Phase 2 SPRING Trial of LHP588, a Next-Generation Gingipain Inhibitor for the Treatment of P. gingivalis-Positive Alzheimer’s Disease, at CTAD 2025
November 26, 2025
·
2 min read
1 of 86,539
Next
